Last $22.88 USD
Change Today -0.16 / -0.69%
Volume 372.9K
GMED On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

globus medical inc - a (GMED) Key Developments

Globus Medical, Inc. Presents at Canaccord Genuity Musculoskeletal Conference, Mar-11-2014 01:00 PM

Globus Medical, Inc. Presents at Canaccord Genuity Musculoskeletal Conference, Mar-11-2014 01:00 PM. Venue: Sheraton New Orleans Hotel, 500 Canal Street, New Orleans, Louisiana, United States.

Globus Medical, Inc. announced delayed annual 10-K filing

On 03/03/2014, Globus Medical, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Globus Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013

Globus Medical, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2013. For the quarter, the company reported sales of $115,245,000 compared to $100,536,000 a year ago. Operating income was $31,747,000 compared to $29,110,000 a year ago. Income before income taxes was $31,820,000 compared to $29,094,000 a year ago. Net income was $20,985,000 or $0.22 basic and diluted per share compared to $20,767,000 or $0.22 diluted per share a year ago. Non-GAAP net income was $24,022,000 or $0.25 diluted per share compared to $20,777,000 or $0.22 diluted per share a year ago. Free cash flow was $27,453,000 compared to $17,086,000 a year ago. Adjusted EBITDA was $42,934,000 compared to $34,761,000 a year ago. For the year, the company reported sales of $434,459,000 compared to $385,994,000 a year ago. Operating income was $101,673,000 compared to $114,793,000 a year ago. Income before income taxes was $102,001,000 compared to $114,653,000 a year ago. Net income was $68,612,000 or $0.73 diluted per share compared to $73,831,000 or $0.80 diluted per share a year ago. Net cash provided by operating activities was $93,471,000 compared to $76,519,000 a year ago. Purchases of property and equipment were $23,680,000 compared to $24,684,000 a year ago. Non-GAAP net income was $84,362,000 or $0.90 diluted per share compared to $73,336,000 or $0.79 diluted per share a year ago. Free cash flow was $69,791,000 compared to $51,835,000 a year ago. Adjusted EBITDA was $150,543,000 compared to $136,649,000 a year ago.

Globus Medical, Inc., Q4 2013 Earnings Call, Feb 26, 2014

Globus Medical, Inc., Q4 2013 Earnings Call, Feb 26, 2014

Globus Medical, Inc. to Report Q4, 2013 Results on Feb 26, 2014

Globus Medical, Inc. announced that they will report Q4, 2013 results on Feb 26, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GMED:US $22.88 USD -0.16

GMED Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.42 USD +0.02
Integra LifeSciences Holdings Corp $45.30 USD -0.22
LDR Holding Corp $25.12 USD +0.61
NuVasive Inc $33.83 USD +0.40
Orthofix International NV $31.51 USD +0.29
View Industry Companies
 

Industry Analysis

GMED

Industry Average

Valuation GMED Industry Range
Price/Earnings 31.6x
Price/Sales 4.9x
Price/Book 4.6x
Price/Cash Flow 31.4x
TEV/Sales 4.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLOBUS MEDICAL INC - A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.